US, China trials show single nanodrug shot may cut LDL cholesterol long-term

Two early-stage clinical trials, one in the US and one in China, suggest a single injection of a nanodrug could suppress LDL cholesterol for extended periods, potentially replacing daily statins. The mechanism and durability remain unproven beyond trial data, and regulatory approval is years away. If validated, this would mark a major shift in cardiovascular prevention, but current evidence is preliminary.